![]()
|
|
||||||||
(Received for publication, December 11, 1995, and in revised form, April 30, 1996)
From the Digestive Diseases Branch, National Institute of Diabetes,
and Digestive and Kidney Diseases, National Institutes of Health,
Bethesda, Maryland 20892
Alternative splicing of two exons of the rat
pituitary adenylate cyclase activating polypeptide (PACAP) receptor
gene generates four major splice variants that are differentially
expressed in specific tissues and variably coupled to intracellular
second messengers. To evaluate the potential implications of these
findings in human physiology, the human PACAP receptor gene was cloned.
Alternative splicing about two exons of the gene allowed for four major
splice variants that were subsequently identified on cDNA cloning.
Each of the four splice variant cDNAs (null, SV-1, SV-2, and SV-3)
was stably expressed in NIH/3T3 cells at similar receptor densities.
For each splice variant, PACAP (both PACAP-38 and PACAP-27) had similar
affinity and potency for stimulating either adenylate cyclase or
phospholipase C. However, each receptor splice variant differed in
their ligand-stimulated maximal response (efficacy) for total inositol
phosphate accumulation with the SV-2 showing the greatest efficacy,
followed by the null, SV-1, and SV-3 splice variants. Therefore, unlike
the rat, PACAP binds and stimulates signal transduction with nearly
equal affinity and potency for each of the receptor splice variants
although with varying efficacy for the stimulation of phospholipase C. These results suggest a novel and potentially important mechanism for a
single hormone to not only couple to dual signal transduction cascades
but also elicit tissue-specific differential activation of
phospholipase C in humans.
Volume 271, Number 29,
Issue of July 19, 1996
pp. 17267-17274
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
EVIDENCE FOR DUAL COUPLING TO ADENYLATE CYCLASE AND
PHOSPHOLIPASE C
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Ushiyama, R. Ikeda, H. Sugawara, M. Yoshida, K. Mori, K. Kangawa, K. Inoue, K. Yamada, and A. Miyata Differential Intracellular Signaling through PAC1 Isoforms as a Result of Alternative Splicing in the First Extracellular Domain and the Third Intracellular Loop Mol. Pharmacol., July 1, 2007; 72(1): 103 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mustafa, M. Grimaldi, and L. E. Eiden The Hop Cassette of the PAC1 Receptor Confers Coupling to Ca2+ Elevation Required for Pituitary Adenylate Cyclase-activating Polypeptide-evoked Neurosecretion J. Biol. Chem., March 16, 2007; 282(11): 8079 - 8091. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chi-Wei, S.-L. Chang, and C.-F. Weng Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Regulates the Expression of PACAP in Cultured Tilapia Astrocytes Experimental Biology and Medicine, February 1, 2007; 232(2): 262 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wei, K. Fujiki, E. Ando, S. Zhang, T. Ozaki, H. Ishiguro, T. Kondo, K. Nokihara, V. Wray, and S. Naruse Identification of key residues that cause differential gallbladder response to PACAP and VIP in the guinea pig Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G76 - G83. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhou, J. Huang, and K. S. Murthy Molecular cloning and functional expression of a VIP-specific receptor. Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G728 - G734. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Roosterman, T. Goerge, S. W. Schneider, N. W. Bunnett, and M. Steinhoff Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev, October 1, 2006; 86(4): 1309 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, S. Cortez, T. Nakamachi, V. Batuman, and A. Arimura Pituitary Adenylate Cyclase-Activating Polypeptide Is a Potent Inhibitor of the Growth of Light Chain-Secreting Human Multiple Myeloma Cells. Cancer Res., September 1, 2006; 66(17): 8796 - 8803. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado, D. Pozo, and D. Ganea The Significance of Vasoactive Intestinal Peptide in Immunomodulation Pharmacol. Rev., June 1, 2004; 56(2): 249 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, A. O. L. Wong, and W. Ge Cloning, Regulation of Messenger Ribonucleic Acid Expression, and Function of a New Isoform of Pituitary Adenylate Cyclase-Activating Polypeptide in the Zebrafish Ovary Endocrinology, November 1, 2003; 144(11): 4799 - 4810. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Payet, L. Bilodeau, L. Breault, A. Fournier, L. Yon, H. Vaudry, and N. Gallo-Payet PAC1 Receptor Activation by PACAP-38 Mediates Ca2+ Release from a cAMP-dependent Pool in Human Fetal Adrenal Gland Chromaffin Cells J. Biol. Chem., January 10, 2003; 278(3): 1663 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Drahushuk, T. D. Connell, and D. Higgins Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Inhibit Dendritic Growth in Cultured Sympathetic Neurons J. Neurosci., August 1, 2002; 22(15): 6560 - 6569. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-Q. Teng, J. R. Grider, and K. S. Murthy Identification of a VIP-specific receptor in guinea pig tenia coli Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G718 - G725. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Filipsson, M. Kvist-Reimer, and B. Ahren The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide and Islet Function Diabetes, September 1, 2001; 50(9): 1959 - 1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Minneman Splice Variants of GPCRs Mol. Interv., June 1, 2001; 1(2): 108 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. McCulloch, E. M. Lutz, M. S. Johnson, D. N. Robertson, C. J. MacKenzie, P. J. Holland, and R. Mitchell ADP-Ribosylation Factor-Dependent Phospholipase D Activation by VPAC Receptors and a PAC1 Receptor Splice Variant Mol. Pharmacol., June 1, 2001; 59(6): 1523 - 1532. [Abstract] [Full Text] |
||||
![]() |
T. E. Solomon, G. Varga, N. Zeng, S. V. Wu, J. H. Walsh, and J. R. Reeve Jr. Different actions of secretin and Gly-extended secretin predict secretin receptor subtypes Am J Physiol Gastrointest Liver Physiol, January 1, 2001; 280(1): G88 - G94. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vaudry, B. J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions Pharmacol. Rev., June 1, 2000; 52(2): 269 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Scaldaferri, A. Modesti, C. Palumbo, S. Ulisse, A. Fabbri, E. Piccione, G. Frajese, and C. Moretti Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and PACAP-Receptor Type 1 Expression in Rat and Human Placenta Endocrinology, March 1, 2000; 141(3): 1158 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Busto, I. Carrero, L. G. Guijarro, R. M. Solano, J. Zapatero, F. Noguerales, and J. C. Prieto Expression, pharmacological, and functional evidence for PACAP/VIP receptors in human lung Am J Physiol Lung Cell Mol Physiol, July 1, 1999; 277(1): L42 - L48. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Martinez-Fuentes, J. P. Castano, F. Gracia-Navarro, and M. M. Malagon Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) 38 and PACAP27 Activate Common and Distinct Intracellular Signaling Pathways to Stimulate Growth Hormone Secretion from Porcine Somatotropes Endocrinology, December 1, 1998; 139(12): 5116 - 5124. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohtaki, K. Ogi, Y. Masuda, K. Mitsuoka, Y. Fujiyoshi, C. Kitada, H. Sawada, H. Onda, and M. Fujino Expression, Purification, and Reconstitution of Receptor for Pituitary Adenylate Cyclase-activating Polypeptide. LARGE-SCALE PURIFICATION OF A FUNCTIONALLY ACTIVE G PROTEIN-COUPLED RECEPTOR PRODUCED IN SF9 INSECT CELLS J. Biol. Chem., June 19, 1998; 273(25): 15464 - 15473. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Harmar, A. Arimura, I. Gozes, L. Journot, M. Laburthe, J. R. Pisegna, S. R. Rawlings, P. Robberecht, S. I. Said, S. P. Sreedharan, et al. International Union of Pharmacology. XVIII. Nomenclature of Receptors for Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Pharmacol. Rev., June 1, 1998; 50(2): 265 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yon, L. Breault, V. Contesse, G. Bellancourt, C. Delarue, A. Fournier, J.-G. Lehoux, H. Vaudry, and N. Gallo-Payet Localization, Characterization, and Second Messenger Coupling of Pituitary Adenylate Cyclase-Activating Polypeptide Receptors in the Fetal Human Adrenal Gland during the Second Trimester of Gestation J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1299 - 1305. [Abstract] [Full Text] |
||||
![]() |
V. Bodart, K. Babinski, H. Ong, and A. De Lean Comparative Effect of Pituitary Adenylate Cyclase-Activating Polypeptide on Aldosterone Secretion in Normal Bovine and Human Tumorous Adrenal Cells Endocrinology, February 1, 1997; 138(2): 566 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-M. Lyu, P. M. Germano, J. K. Choi, S. V. Le, and J. R. Pisegna Identification of an Essential Amino Acid Motif within the C Terminus of the Pituitary Adenylate Cyclase-activating Polypeptide Type I Receptor That Is Critical for Signal Transduction but Not for Receptor Internalization J. Biol. Chem., November 10, 2000; 275(46): 36134 - 36142. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Daniel, T. J. Kieffer, C. A. Leech, and J. F. Habener Novel Alternatively Spliced Exon in the Extracellular Ligand-binding Domain of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Type 1 Receptor (PAC1R) Selectively Increases Ligand Affinity and Alters Signal Transduction Coupling during Spermatogenesis J. Biol. Chem., April 13, 2001; 276(16): 12938 - 12944. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |